Shorter drug treatment OK for many breast cancer patients
Many women with a common and aggressive form of breast cancer that is treated with Herceptin can get by with six months of the drug instead of the usual 12, greatly reducing the risk of heart damage it sometimes can cause, a study suggests.
It's good news, but it comes nearly two decades after the drug first went on the market and many patients have suffered that side effect.
The study was done in the United Kingdom and funded by UK government grants. Results were released Wednesday by the American Society of Clinical Oncology and will be presented at the group's meeting next month.... read more
- 11:57 Sutherland Springs survivor urges gun owners to push back against NRA
- 11:18 The Latest: US team heading to Singapore to work on summit
- 10:19 Family grateful for Utah man's 'miracle' Venezuela release
- 09:36 Resistance makes subtle impact even where Trump is popular
- 02:03 Giuliani says White House wants briefing on classified info
- 01:02 Trump stays out of messy House immigration fight
- 00:46 Trump shifts stance on Korea summit from 'off' to 'maybe'
- 00:46 Trump's dizzying shifts on issues from NK, guns, health care